Medical Writer

About Prilenia

Prilenia Therapeutics, a clinical-stage biotech company focused on the urgent mission of developing novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, is looking for a Principal/Senior Medical Writer to join its team in the EU/IL.

We are a flexible, fast-moving team that is quickly advancing a potential therapy poised to have major impact on the lives of patients and their families. Our lead product candidate, pridopidine, holds Orphan Drug Designation in both Huntington’s disease (HD) and Amyotrophic lateral Sclerosis Amyotrophic (ALS) in the US and EU, as well as Fast Track designation from the FDA for the treatment of HD. Prilenia is working on preparing for regulatory filing for HD in European Union and for starting a global phase 3 study in ALS with pridopidine.

Pridopidine has the potential to be the first treatment to address HD disease clinical progression. Prilenia also believes pridopi Apply now and work remotely at Prilenia